Serum creatinine level and ESR values associated to clinical pathology types and prognosis of patients with renal injury caused by ANCA-associated vasculitis
暂无分享,去创建一个
M. Xin | Mingshu Sun | Jibo Wang | Hongda Liang | Lei Zhao | Liqin Wang
[1] C. Pusey,et al. The Histopathological Classification of ANCA-associated Glomerulonephritis Comes of Age , 2017, The Journal of Rheumatology.
[2] M. Ge,et al. [Geographical distribution of the Serum creatinine reference values of healthy adults]. , 2016, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.
[3] S. El-Sayegh,et al. Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis , 2015, BioMed research international.
[4] W. van Biesen,et al. Prognostic robustness of serum creatinine based AKI definitions in patients with sepsis: a prospective cohort study , 2015, BMC Nephrology.
[5] A. Hanssen,et al. Seronegative infections in hip and knee arthroplasty: periprosthetic infections with normal erythrocyte sedimentation rate and C-reactive protein level. , 2015, The bone & joint journal.
[6] L. Wang,et al. Neutrophil extracellular trap formation is associated with autophagy‐related signalling in ANCA‐associated vasculitis , 2015, Clinical and experimental immunology.
[7] E. Giovannucci,et al. Adolescent body mass index and erythrocyte sedimentation rate in relation to colorectal cancer risk , 2015, Gut.
[8] A. Sanyal,et al. P0198 : Percentage change in serum creatinine (SCr) is a sensitive indicator of therapeutic response to terlipressin in hepatorenal syndrome type 1 (HRS-1) , 2015 .
[9] H. Sung,et al. Clinical significance of prognosis using the neutrophil–lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma , 2015, BJU international.
[10] P. van Paassen,et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial. , 2015, Annals of the rheumatic diseases.
[11] K. Konstantinov,et al. Infections and antineutrophil cytoplasmic antibodies: triggering mechanisms. , 2015, Autoimmunity reviews.
[12] N. Chen,et al. Clinical and Pathological Study on Patients With Primary Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis With Renal Immune Complex Deposition , 2015, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[13] Masahiro Ito,et al. Successful Management of Lupus Nephritis with High Titers of Myeloperoxidase Anti-Neutrophil Cytoplasmic Antibodies Using Tacrolimus. , 2015, Internal medicine.
[14] M. Solé,et al. ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[15] A. Salama,et al. Induction treatment of ANCA-associated vasculitis with a single dose of rituximab. , 2014, Rheumatology.
[16] V. Jha,et al. Histopathological classification of pauci-immune glomerulonephritis and its impact on outcome , 2014, Rheumatology International.
[17] P. Höglund,et al. Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear. , 2013, Kidney international.
[18] A. Salama,et al. Induction treatment of ANCA associated vasculitis with a single dose of rituximab , 2013 .
[19] P. Paassen,et al. Estimating renal survival using the ANCA-associated glomerulonephritis classification: A validation study , 2013 .
[20] I. Bajema,et al. L21. Kidneys in ANCA-associated vasculitis: what to learn from biopsies? , 2013, Presse medicale.
[21] S. Wieczorek,et al. The future of ANCA-associated vasculitis. , 2010, Rheumatic diseases clinics of North America.
[22] C. Pusey,et al. The Histopathological Classification of ANCA-associated Glomerulonephritis Comes of Age , 2017, The Journal of Rheumatology.
[23] M. Ge,et al. [Geographical distribution of the Serum creatinine reference values of healthy adults]. , 2016, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.
[24] S. El-Sayegh,et al. Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis , 2015, BioMed research international.
[25] W. van Biesen,et al. Prognostic robustness of serum creatinine based AKI definitions in patients with sepsis: a prospective cohort study , 2015, BMC Nephrology.
[26] A. Hanssen,et al. Seronegative infections in hip and knee arthroplasty: periprosthetic infections with normal erythrocyte sedimentation rate and C-reactive protein level. , 2015, The bone & joint journal.
[27] L. Wang,et al. Neutrophil extracellular trap formation is associated with autophagy‐related signalling in ANCA‐associated vasculitis , 2015, Clinical and experimental immunology.
[28] E. Giovannucci,et al. Adolescent body mass index and erythrocyte sedimentation rate in relation to colorectal cancer risk , 2015, Gut.
[29] A. Sanyal,et al. P0198 : Percentage change in serum creatinine (SCr) is a sensitive indicator of therapeutic response to terlipressin in hepatorenal syndrome type 1 (HRS-1) , 2015 .
[30] H. Sung,et al. Clinical significance of prognosis using the neutrophil–lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma , 2015, BJU international.
[31] P. van Paassen,et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial. , 2015, Annals of the rheumatic diseases.
[32] K. Konstantinov,et al. Infections and antineutrophil cytoplasmic antibodies: triggering mechanisms. , 2015, Autoimmunity reviews.
[33] N. Chen,et al. Clinical and Pathological Study on Patients With Primary Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis With Renal Immune Complex Deposition , 2015, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[34] Masahiro Ito,et al. Successful Management of Lupus Nephritis with High Titers of Myeloperoxidase Anti-Neutrophil Cytoplasmic Antibodies Using Tacrolimus. , 2015, Internal medicine.
[35] M. Solé,et al. ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[36] A. Salama,et al. Induction treatment of ANCA-associated vasculitis with a single dose of rituximab. , 2014, Rheumatology.
[37] V. Jha,et al. Histopathological classification of pauci-immune glomerulonephritis and its impact on outcome , 2014, Rheumatology International.
[38] P. Höglund,et al. Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear. , 2013, Kidney international.
[39] A. Salama,et al. Induction treatment of ANCA associated vasculitis with a single dose of rituximab , 2013 .
[40] P. Paassen,et al. Estimating renal survival using the ANCA-associated glomerulonephritis classification: A validation study , 2013 .
[41] I. Bajema,et al. L21. Kidneys in ANCA-associated vasculitis: what to learn from biopsies? , 2013, Presse medicale.